Table 4 Estimated parameters by linear regressions, and t-test p-values testing post-pandemic < = pre-pandemic
From: ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?
Country | Regression slope pre-pandemic | Regression slope post-pandemic | p-value one-sided t-test |
|---|---|---|---|
Austria | 0.014 | 0.068 | 0.000 |
Belgium | 0.047 | 0.073 | 0.068 |
Bulgaria | 0.000 | 0.001 | 0.013 |
Croatia | 0.001 | 0.002 | 0.111 |
Czech Republic | 0.015 | 0.030 | 0.000 |
Denmark | 0.197 | 0.667 | 0.000 |
Estonia | 0.022 | 0.182 | 0.000 |
Finland | 0.159 | 0.609 | 0.000 |
France | 0.015 | 0.050 | 0.000 |
Germany | 0.033 | 0.110 | 0.000 |
Greece | 0.003 | 0.012 | 0.000 |
Hungary | 0.006 | 0.016 | 0.000 |
Ireland | 0.030 | 0.102 | 0.000 |
Italy | 0.003 | 0.004 | 0.000 |
Latvia | 0.004 | 0.023 | 0.000 |
Lithuania | 0.003 | 0.016 | 0.000 |
Luxembourg | -0.020 | 0.103 | 0.000 |
Netherlands | 0.042 | 0.270 | 0.000 |
Norway | 0.236 | 0.694 | 0.000 |
Poland | 0.008 | 0.059 | 0.000 |
Portugal | 0.015 | 0.164 | 0.000 |
Romania | -0.001 | 0.011 | 0.002 |
Slovakia | 0.003 | 0.009 | 0.000 |
Slovenia | 0.008 | 0.037 | 0.000 |
Spain | 0.021 | 0.069 | 0.000 |
Sweden | 0.292 | 0.588 | 0.000 |
Switzerland | 0.060 | 0.243 | 0.000 |
UK | 0.043 | 0.179 | 0.000 |